These benefits, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the strategy of targeting ACKR3 as a novel way to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Conditions. Disclaimer: The above mentioned is usually https://helenz935btk7.smblogsites.com/profile